Real-World Data on Therapies for Relapsed or Refractory Multiple Myeloma: Key Data from ASH 2023—A Podcast
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Real-World Data on Therapies for Relapsed or Refractory Multiple Myeloma: Key Data from ASH 2023—A Podcast ; day:20 ; month:4 ; year:2024 ; pages:1-11
Advances in therapy ; (20.4.2024), 1-11
- Urheber
-
Costa, Luciano J.
Rodriguez-Otero, Paula
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s12325-024-02842-9
- URN
-
urn:nbn:de:101:1-2407022100427.450502153130
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:55 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Costa, Luciano J.
- Rodriguez-Otero, Paula
- SpringerLink (Online service)
Ähnliche Objekte (12)
Bispecific Monoclonal Antibodies in Multiple Myeloma: Data from ASH 2022: A Podcast
ASH highlights 2022—multiple myeloma
Immunotherapies targeting GPRC5D in relapsed or refractory multiple myeloma: latest updates from 2022 ASH Annual Meeting
ASH 2018—Highlights in Multiple Myeloma
Multiple myeloma: my highlights at ASH 2020
Chronic Myeloid Leukemia Data at ASH 2021: A Podcast on Patient Unmet Needs and Later-Line Treatment Developments
Accelerated single cell seeding in relapsed multiple myeloma
Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma
Management of Relapsed and Refractory Multiple Myeloma: Recent advances
Target trial emulation of carfilzomib safety among patients with relapsed/refractory multiple myeloma using a nationwide observational data in Korea
VolcAshDB: a Volcanic Ash DataBase of classified particle images and features
Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study
Bispecific Monoclonal Antibodies in Multiple Myeloma: Data from ASH 2022: A Podcast
ASH highlights 2022—multiple myeloma
Immunotherapies targeting GPRC5D in relapsed or refractory multiple myeloma: latest updates from 2022 ASH Annual Meeting
ASH 2018—Highlights in Multiple Myeloma
Multiple myeloma: my highlights at ASH 2020
Chronic Myeloid Leukemia Data at ASH 2021: A Podcast on Patient Unmet Needs and Later-Line Treatment Developments
Accelerated single cell seeding in relapsed multiple myeloma
Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma
Management of Relapsed and Refractory Multiple Myeloma: Recent advances
Target trial emulation of carfilzomib safety among patients with relapsed/refractory multiple myeloma using a nationwide observational data in Korea
VolcAshDB: a Volcanic Ash DataBase of classified particle images and features
Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study
Bispecific Monoclonal Antibodies in Multiple Myeloma: Data from ASH 2022: A Podcast
ASH highlights 2022—multiple myeloma
Immunotherapies targeting GPRC5D in relapsed or refractory multiple myeloma: latest updates from 2022 ASH Annual Meeting
ASH 2018—Highlights in Multiple Myeloma
Multiple myeloma: my highlights at ASH 2020
Chronic Myeloid Leukemia Data at ASH 2021: A Podcast on Patient Unmet Needs and Later-Line Treatment Developments
Accelerated single cell seeding in relapsed multiple myeloma
Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma
Management of Relapsed and Refractory Multiple Myeloma: Recent advances
Target trial emulation of carfilzomib safety among patients with relapsed/refractory multiple myeloma using a nationwide observational data in Korea
VolcAshDB: a Volcanic Ash DataBase of classified particle images and features